Episode 1: GBL's Healthcare Play, Agomab's Nasdaq Debut & The Battle for Warner Bros

Episode 1: The Finance Show LaunchesWelcome to the first episode of The Finance Show, your biweekly briefing on Belgian and global corporate finance.In this episode:Belgian deals: GBL invests €500M in UK medtech Rayner as part of its healthcare pivot. John Cockerill raises €300M to fund defense and hydrogen expansion. Belgian biotech Agomab goes public on Nasdaq for $200M, choosing US markets over Brussels.Global M&A battle: Netflix's $83B deal for Warner Bros. Discovery faces Paramount's hostile $108B counter-bid. We break down the timeline, the players, and the March 20th shareholder vote that decides everything.Trade policy: US court blocks Trump tariffs, Trump vows new 10% global levy. What it means for markets and corporate strategy.Analysis, context, and what's next, all in one episode.New episodes every two weeks.